While HSC transplantation can be life saving for patients with aggressive forms of blood cancer that are unresponsive to other available treatments, there are many risks associated with the procedure. A new study in the Journal of Clinical Investigation demonstrates that targeting T and B cells has potential to ameliorate chronic GVDH.
http://ift.tt/1pVFhHe
http://ift.tt/1pVFhHe
No comments:
Post a Comment